prikaz prve stranice dokumenta Kirurško liječenje malignih bolesti štitnjače
  Download
PDF 585.67 KB
master's thesis
Kirurško liječenje malignih bolesti štitnjače
diplomski rad
2023. urn:nbn:hr:184:598083
Matan, Ana Marija
University of Rijeka
Faculty of Medicine
Department of Surgery

Cite this document

Matan, A. M. (2023). Kirurško liječenje malignih bolesti štitnjače : diplomski rad (Master's thesis). Rijeka: University of Rijeka, Faculty of Medicine. Retrieved from https://urn.nsk.hr/urn:nbn:hr:184:598083

Matan, Ana Marija. "Kirurško liječenje malignih bolesti štitnjače : diplomski rad." Master's thesis, University of Rijeka, Faculty of Medicine, 2023. https://urn.nsk.hr/urn:nbn:hr:184:598083

Matan, Ana Marija. "Kirurško liječenje malignih bolesti štitnjače : diplomski rad." Master's thesis, University of Rijeka, Faculty of Medicine, 2023. https://urn.nsk.hr/urn:nbn:hr:184:598083

Matan, A. M. (2023). 'Kirurško liječenje malignih bolesti štitnjače : diplomski rad', Master's thesis, University of Rijeka, Faculty of Medicine, accessed 15 November 2024, https://urn.nsk.hr/urn:nbn:hr:184:598083

Matan AM. Kirurško liječenje malignih bolesti štitnjače : diplomski rad [Master's thesis]. Rijeka: University of Rijeka, Faculty of Medicine; 2023 [cited 2024 November 15] Available at: https://urn.nsk.hr/urn:nbn:hr:184:598083

A. M. Matan, "Kirurško liječenje malignih bolesti štitnjače : diplomski rad", Master's thesis, University of Rijeka, Faculty of Medicine, Rijeka, 2023. Available at: https://urn.nsk.hr/urn:nbn:hr:184:598083

Please login to the repository to save this object to your list.
Metadata
TitleKirurško liječenje malignih bolesti štitnjače : diplomski rad
Title (english)Surgical treatment of malignant thyroid diseases
AuthorAna Marija Matan
MentorDamir Grebić (mentor)
Committee memberSanja Klobučar-Majanović (predsjednik povjerenstva)
Committee memberFranjo Lovasić (član povjerenstva)
Committee memberDubravko Manestar (član povjerenstva)
GranterUniversity of Rijeka
Faculty of Medicine
(Department of Surgery)
Rijeka
Defense date and country2023-07-14, Croatia
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Surgery
Abstract
Primarna terapija za diferencirani (papilarni i folikularni) rak štitnjače je operacija. Svi pacijenti trebaju imati preoperativnu ultrazvučnu procjenu centralnih i lateralnih limfnih čvorova vrata kako bi se mogao planirati kirurški zahvat. Kirurške opcije uključuju tireoidektomiju i lobektomiju. Kurativnu resekciju treba izvoditi kad god je to moguće kod anaplastičnog raka. Unatoč razvoju i raznolikosti liječenja, optimalno liječenje anaplastičnog karcinoma štitnjače još nije potvrđeno. Čini se da kurativna resekcija anaplastičnog karcinoma štitnjače sa kombiniranim terapijama nudi mogućnost kontrole recidiva i veće šanse za preživljenje pacijenata. Kombinirane terapije uključuju radioterapiju i kemoterapiju. Bolesnici s medularnim karcinomom štitnjače mogu se izliječiti samo potpunom resekcijom tumora štitnjače i bilo kojim lokalnim i regionalnim metastazama. Za pacijente s rezidualnom oblikom bolesti ili za one s udaljenim metastazama, nakon primarne operacije najprikladnije liječenje (operacija, kemoterapija ili radioterapija) je manje jasno.
Abstract (english)
The primary therapy for differentiated (papillary and follicular) thyroid cancer is surgery. All patients should have a preoperative ultrasound evaluation of the central and lateral neck lymph nodes in order to plan the surgical procedure. Surgical options include thyroidectomy and lobectomy. Surgery, particularly curative resection, should be performed whenever possible in anaplastic cancer. Despite the development and diversity of the treatment, optimal treatment for anaplastic thyroid carcinoma has not yet been confirmed. It appears that curative resection of the anaplastic thyroid carcinoma with combination therapies offers the chance of controlling recurence and a better chance of patients’ survival. The combination therapies include radiotherapy and chemotherapy. Patients with medullary thyroid cancer can be cured only by complete resection of the thyroid tumor and any local and regional metastases. For patients with residual or recurrent disease after primary surgery or for those with distant metastases, the most appropriate treatment (surgery, chemotherapy, or radiotherapy) is less clear.
Keywords
Keywords (english)
Languagecroatian
URN:NBNurn:nbn:hr:184:598083
Study programmeTitle: Medicine
Study programme type: university
Study level: integrated undergraduate and graduate
Academic / professional title: doktor/doktorica medicine (doktor/doktorica medicine)
Type of resourceText
File originBorn digital
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2023-07-09 13:02:31